CDK6 and hepatocellular carcinoma: To further verify the results acquired with shotgun proteomics, we employed an alternative mass spectrometry (MS) method, namely, parallel reaction monitoring (PRM), to quantify the change in CDK6 more accurately, and we observed a consistent increase in CDK6 in lenvatinib-resistant HCC (Fig. 1g).